The research of cerebrovascular disease

February 2020 was a thrilling month for our speakers.
We were delighted to join yet another prominent event in the industry, the prestigious International Stroke Conference, organized by the American Heart Association. ISC is the leading conference dedicated to the science and treatment of cerebrovascular disease.

The ISC is a must-attend event for any professional involved in the stroke medical profession interested in hearing the very latest significant trial results and in engaging with the research community.

The selection of SENSE Diagnostics to present its first-in-human study at the ISC testifies to the importance of our research and the interest it generated among peer reviewers who vet conference submissions. Dr. Matthew Flaherty, our CCO, shared the findings of our first-in-human study.